News Sentiment

CV sentiment intelligence

CapsoVision, Inc. Common Stock news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 52 Balanced news tone 51 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Medical Devices Read-through group
Latest close 6.71 Week of 17 Jul 2026
Weighted tone 52/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

78/100 classification confidence.

Company focus 41

directly relevant articles

Source quality 3

high-authority source matches

Trend context Trend inactive

+12.0% over one week, +1.5% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Neutral

Abbott stock trades steady as diagnostics and medical devices underpin earnings momentum

Market Reaction

Price moving ahead of tone

60/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 78/100 classification
One-week reaction 12.0% Price confirming higher
Trend fit Trend inactive 1.5% over four weeks
Fair value 11.2% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 15
Neutral 27
Negative 9

Relevance

Why the article matched

Direct first
Direct company coverage 41
Industry context 10
Sector context 0

Sources

Coverage mix

Publishers
Market source 13
TradingView 10
Stock Titan 4
Investing.com 3
Ad-hoc-news.de 2
Investing.com South Africa 2
marketscreener.com 2
Barron's 2

Event Lens

What the news is about

Classified themes
Market update 24
Earnings 21
Analyst action 5
Deals and strategy 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 51
Investing.com Nigeria Direct company coverage

CapsoVision 10% owner Eliyahou Harari buys $495,117 in stock By Investing.com

Eliyahou Harari, a 10% owner of CapsoVision Inc., purchased 81,300 shares of the company's common stock for $495,117, despite the stock's recent decline and overvalued assessment by InvestingPro. This insider transaction follows the company's first-quarter 2026 earnings miss and

Tone
Neutral 50/100
Event
Earnings
Published
11 Jul 2026 15:11
Source
Investing.com Nigeria
Investing.com South Africa Direct company coverage

Form 4 CapsoVision Inc For: 10 July By Investing.com

This article from Investing.com is a brief financial update indicating the filing of a Form 4 for CapsoVision Inc. on July 10. The article is very short and primarily serves as a notification, mentioning a 3.81% increase for the company's stock symbol CV.

Tone
Positive 60/100
Event
Market update
Published
11 Jul 2026 14:11
Source
Investing.com South Africa
Simply Wall Street Direct company coverage

Insider Buyers Lose US$22k As CapsoVision Sheds US$75m

Insiders at CapsoVision (NASDAQ:CV) who purchased US$101.8k worth of stock at an average price of US$7.35 over the past year have seen their investment decrease by 21%, now worth US$79.9k. Despite this loss, the single insider purchase by Britt Harari at a price above the current

Tone
Negative 35/100
Event
Market update
Published
10 Jul 2026 10:39
Source
Simply Wall Street
Investing.com UK Direct company coverage

Form 4 CapsoVision Inc For: 7 July By Investing.com

This article announces the filing of Form 4 for CapsoVision Inc. on July 7th, as reported by Investing.com. It is a brief financial news update providing disclosure of insider transactions for the company, identified by the stock symbol CV.

Tone
Neutral 50/100
Event
Market update
Published
08 Jul 2026 02:40
Source
Investing.com UK
Investing.com Direct company coverage

CapsoVision 10% owner Eliyahou Harari buys $101,811 in CV stock

Eliyahou Harari, a 10% owner of CapsoVision, Inc. (CV), purchased 13,850 shares of the company's common stock for $101,811 on June 26, 2026, at $7.351 per share. This insider purchase occurred despite the stock currently trading at $5.67, approximately 23% below his purchase pric

Tone
Negative 39/100
Event
Market update
Published
08 Jul 2026 02:11
Source
Investing.com
GlobeNewswire Direct company coverage

CapsoVision Appoints Gastroenterology Leader David S. Shields, M.D., to Board of Directors

CapsoVision, Inc. has appointed Dr. David S. Shields, a distinguished gastroenterologist with over 40 years of experience, to its Board of Directors, effective July 1, 2026. Dr. Shields has been a clinical advisor to CapsoVision for nearly a decade and will bring extensive expert

Tone
Positive 74/100
Event
Market update
Published
03 Jul 2026 11:40
Source
GlobeNewswire
Moomoo Direct company coverage

Press Release: CapsoVision Appoints Gastroenterology Leader David S. Shields, M.D., to Board of Directors

CapsoVision, Inc., a company focused on advanced capsule endoscopy solutions, announced the appointment of Dr. David S. Shields, a prominent leader in gastroenterology, to its Board of Directors. Dr. Shields brings extensive experience in GI practice management, clinical research

Tone
Positive 74/100
Event
Market update
Published
02 Jul 2026 23:40
Source
Moomoo
Investing.com Direct company coverage

CapsoVision appoints gastroenterologist David Shields to board

CapsoVision, Inc. has appointed Dr. David S. Shields, a board-certified gastroenterologist with over 40 years of experience, to its Board of Directors. Dr. Shields has served as a clinical advisor to CapsoVision for nearly a decade and succeeds Dr. Joanne C. Imperial, who will co

Tone
Positive 60/100
Event
Market update
Published
02 Jul 2026 21:13
Source
Investing.com
Stock Titan Direct company coverage

Gastroenterology leader Shields joins CapsoVision (Nasdaq: CV) board as Imperial shifts to consulting

CapsoVision, Inc. (Nasdaq: CV) has appointed Dr. David S. Shields, a prominent gastroenterologist, to its Board of Directors and Compensation Committee, effective July 1, 2026. Dr. Shields replaces Dr. Joanne Imperial, who resigned from the board but will continue to serve CapsoV

Tone
Positive 65/100
Event
Market update
Published
02 Jul 2026 20:09
Source
Stock Titan
Stock Titan Direct company coverage

Director at CapsoVision (CV) awarded 1,710 RSUs vesting in 2026

CapsoVision, Inc. director David Stanley Shields has been awarded 1,710 Restricted Stock Units (RSUs) as a compensation grant, with each RSU representing a contingent right to receive one share of common stock. These RSUs were granted at a price of $0.0000 per unit and are schedu

Tone
Neutral 50/100
Event
Market update
Published
02 Jul 2026 20:09
Source
Stock Titan
Stock Titan Direct company coverage

Director Tsai Chen Lung adds CapsoVision (CV) shares via RSU vesting

CapsoVision director Tsai Chen Lung increased his direct equity stake by exercising 2,022 Restricted Stock Units (RSUs) into Common Stock on June 30, 2026. These RSUs were part of an equity incentive award, vesting 50% on June 30 and 50% on December 31 each year. After the transa

Tone
Neutral 50/100
Event
Deals and strategy
Published
02 Jul 2026 13:41
Source
Stock Titan
Investing.com Direct company coverage

CapsoVision director Joanne Imperial sells $8,586 in common stock

CapsoVision director Joanne Imperial sold 1,200 shares of company common stock for $8,586 on June 8, 2026. This transaction occurred amidst news of CapsoVision missing Q1 2026 EPS expectations, though the company has ongoing product development and recently re-elected directors.

Tone
Negative 38/100
Event
Earnings
Published
02 Jul 2026 11:40
Source
Investing.com
Investing.com South Africa Direct company coverage

CapsoVision director Joanne Imperial sells $8,586 in common stock By Investing.com

CapsoVision director Joanne Imperial sold 1,200 shares of company common stock for $8,586 on June 8, 2026. This transaction leaves Ms. Imperial with 1,687 shares, while the stock is currently trading at $7.37, marking a 31% year-to-date decline despite a 110% gain over the past y

Tone
Negative 33/100
Event
Market update
Published
02 Jul 2026 02:09
Source
Investing.com South Africa
Stock Titan Direct company coverage

CapsoVision (CV) director converts RSUs into 2,022 common shares in equity grant vesting

CapsoVision, Inc. director King Wen-Herng Henry converted 2,022 restricted stock units (RSUs) into common shares on June 30, 2026, as part of an equity grant vesting. The shares were acquired at $7.58 each, stemming from an RSU grant made on March 19, 2026, with a fair market val

Tone
Neutral 50/100
Event
Market update
Published
01 Jul 2026 03:13
Source
Stock Titan
marketscreener.com Direct company coverage

CapsoVision, Inc.(NasdaqCM: CV) dropped from Russell 3000 Value Benchmark

CapsoVision, Inc. (NasdaqCM: CV) was dropped from the Russell 3000 Value Benchmark on June 29, 2026. This news follows several other announcements on the same day indicating the company's exclusion from various Russell indices, including the Small Cap Comp Value, Microcap Value,

Tone
Negative 36/100
Event
Market update
Published
29 Jun 2026 23:09
Source
marketscreener.com
marketscreener.com Direct company coverage

CapsoVision, Inc.(NasdaqCM: CV) dropped from Russell Microcap Value Benchmark Index

CapsoVision, Inc. (NasdaqCM: CV) has been removed from the Russell Microcap Value Benchmark Index, as well as several other Russell indices including the Small Cap Comp Value, 3000E Value, 3000 Value, and 2500 Value benchmarks. The company, a global medical device innovator speci

Tone
Negative 20/100
Event
Market update
Published
29 Jun 2026 10:32
Source
marketscreener.com
TradingView Direct company coverage

CapsoVision, Inc. Actuals & Estimates (NASDAQ:CV)

This article provides a detailed financial overview and analyst estimates for CapsoVision, Inc. (NASDAQ:CV). It covers current stock performance, analyst forecasts with price targets, historical highs and lows, volatility, market capitalization, and upcoming earnings reports. The

Tone
Positive 67/100
Event
Earnings
Published
26 Jun 2026 20:39
Source
TradingView
TradingView Direct company coverage

CV Forecast — Price Target — Prediction for 2027

CapsoVision, Inc. (CV) has a current stock price of $7.52, with a 1-year analyst price target forecast ranging from $10.00 (min to max). The stock has seen a 50.40% increase over the last year. Analysts currently rate CV with a "strong buy" signal for both today and the next mont

Tone
Positive 71/100
Event
Analyst action
Published
26 Jun 2026 08:39
Source
TradingView